MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon:A randomized, controlled trialNaomi F. Rothfield, Fredrick M. Wigey, David Fiorentino et al.|Discovery Research Portal (University of Dundee)|2008Cited by 0